BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 26802282)

  • 1. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.
    Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG
    Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
    Richter P; Hodge K; Stanfill S; Zhang L; Watson C
    Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical characterization of domestic oral tobacco products: total nicotine, pH, unprotonated nicotine and tobacco-specific N-nitrosamines.
    Lawler TS; Stanfill SB; Zhang L; Ashley DL; Watson CH
    Food Chem Toxicol; 2013 Jul; 57():380-6. PubMed ID: 23517910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines.
    Hoffmann D; Djordjevic MV; Fan J; Zang E; Glynn T; Connolly GN
    J Natl Cancer Inst; 1995 Dec; 87(24):1862-9. PubMed ID: 7494230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic and carcinogenic agents in dry and moist snuff.
    Hoffmann D; Adams JD; Lisk D; Fisenne I; Brunnemann KD
    J Natl Cancer Inst; 1987 Dec; 79(6):1281-6. PubMed ID: 3480379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007.
    Borgerding MF; Bodnar JA; Curtin GM; Swauger JE
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):367-87. PubMed ID: 23000415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative and quantitative risk assessment of snuff dipping.
    Nilsson R
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):1-16. PubMed ID: 9784428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers.
    Hoffmann D; Adams JD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4305-8. PubMed ID: 7198005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between microbial communities and key chemical constituents in U.S. domestic moist snuff.
    Tyx RE; Rivera AJ; Satten GA; Keong LM; Kuklenyik P; Lee GE; Lawler TS; Kimbrell JB; Stanfill SB; Valentin-Blasini L; Watson CH
    PLoS One; 2022; 17(5):e0267104. PubMed ID: 35507593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smokeless tobacco and oral cancer: a review of the risks and determinants.
    Rodu B; Jansson C
    Crit Rev Oral Biol Med; 2004 Sep; 15(5):252-63. PubMed ID: 15470264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.
    Stepanov I; Biener L; Yershova K; Nyman AL; Bliss R; Parascandola M; Hatsukami DK
    Nicotine Tob Res; 2014 Aug; 16(8):1070-8. PubMed ID: 24604020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenic agents in snuff.
    Hoffmann D; Harley NH; Fisenne I; Adams JD; Brunnemann KD
    J Natl Cancer Inst; 1986 Mar; 76(3):435-7. PubMed ID: 3456461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs).
    Back S; Masser AE; Rutqvist LE; Lindholm J
    BMC Chem; 2023 Mar; 17(1):9. PubMed ID: 36869349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market.
    Osterdahl BG; Jansson C; Paccou A
    J Agric Food Chem; 2004 Aug; 52(16):5085-8. PubMed ID: 15291479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation and analysis of tobacco-specific N-nitrosamines.
    Brunnemann KD; Prokopczyk B; Djordjevic MV; Hoffmann D
    Crit Rev Toxicol; 1996; 26(2):121-37. PubMed ID: 8688156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying toxicological risk assessment principles to constituents of smokeless tobacco products: implications for product regulation.
    Ayo-Yusuf OA; Connolly GN
    Tob Control; 2011 Jan; 20(1):53-7. PubMed ID: 20924040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive chemical characterization of RapĂ© tobacco products: Nicotine, un-ionized nicotine, tobacco-specific N'-nitrosamines, polycyclic aromatic hydrocarbons, and flavor constituents.
    Stanfill SB; Oliveira da Silva AL; Lisko JG; Lawler TS; Kuklenyik P; Tyx RE; Peuchen EH; Richter P; Watson CH
    Food Chem Toxicol; 2015 Aug; 82():50-8. PubMed ID: 25934468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Swedish snus and the Sudanese toombak: are they different?
    Idris AM; Ibrahim SO; Vasstrand EN; Johannessen AC; Lillehaug JR; Magnusson B; Wallström M; Hirsch JM; Nilsen R
    Oral Oncol; 1998 Nov; 34(6):558-66. PubMed ID: 9930371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
    Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
    J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical composition and carcinogenicity of smokeless tobacco.
    Hoffmann D; Djordjevic MV
    Adv Dent Res; 1997 Sep; 11(3):322-9. PubMed ID: 9524432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.